Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic kidney disease
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...
1. Monoclonal antibody (mAb) treatment for mild to moderate coronavirus disease 2019 (COVID-19) in pregnant persons was not associated with ...
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and larger reductions of C-reactive protein (CRP) as ...
1. Compared to placebo, intramuscular AZD7442 had a relative risk reduction of 76.7% for symptomatic incident coronavirus disease 2019 (COVID-19). ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.